Arkolith/Insider Trading/EWTX/Form 4

Fox Jonathan C

DirectorEdgewise Therapeutics, Inc. (EWTX) · full profile →Form 4 · filed Nov 13, 2025
Net Buying
Open-Market Buys
$199K
Open-Market Sells
$0
Net Open-Market Flow
$199K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 11, 2025Buy(P)11K$18.64$199K24K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001655016-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML